James (Jay) Hoying is a Partner and Chief Scientist with more than 25 years of experience in basic and applied biological sciences with a focus in the microcirculation and tissue vascularization.
Previously, he was the Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) where he developed a broad background in tissue fabrication, cell therapeutics, and translation of discoveries to industry and the clinic.
Dr. Hoying is an inventor of the Angiomics microvessel technology and holds numerous patents related to vascularizing tissues and related cell-based therapies. He is one of the first to publish in the area of vascularized tissue model fabrication.
Dr. Hoying received his BA and MS degrees in Biology and Molecular Biology from Case Western Reserve University and his PhD in Cardiovascular Physiology, with an emphasis on the microcirculation, from the University of Arizona.
Following this, Dr. Hoying served as a New Investigator in the National Institutes of Health Program of Excellence in Molecular Biology of the Heart and Lung (POEMB) in the Department of Molecular Genetics at the University of Cincinnati. Dr. Hoying is also a Fellow of the American Heart Association.